期刊文献+

产生复治后耐多药肺结核病的有关因素及临床特点 被引量:10

Related factors and clinical characteristics of the MDR-PTB patients who received treatment before
下载PDF
导出
摘要 目的 了解产生复治后耐多药肺结核病的有关因素及临床特点。方法 对 1992— 2 0 0 2年10年间收治的复治后耐多药肺结核病人 (MDR PTB)共 6 2 5例进行分析。结果  6 2 5例复治后MDR PTB病人占同期收治的复治菌 (阳 )病人的 30 .8% ,青壮年男性占大多数。药敏监测提示耐H、R 7例(1.1% ) ;耐 3种药 12 5例 (2 0 .0 % ) ;耐 4种药 4 93例 (78.9% )。初始耐药 19.4 % ,获得性耐药 80 .6 %。农村及城镇病人比例高 ,但有效率低于城市病人。结论 复治后MDR PTB较普通MDR PTB更难处理 ,除经济、文化、地区等因素外 ,医源性因素也是其发病率增高的重要原因。本组初始耐药感染高于全国平均水平。不同地区治疗有效率差异与缺乏专业人员的正规治疗及管理有关。个体化治疗。 Objective To determine the occurrence mechanism clinical characteristics multidrug resistant pulmonary tuberculosis (MDR PTB) who received treatment before.Methods The clinical data of 625 cases with MDR PTB received treatment before in Guiyang pulmonary Hospital from 1992 to 2002 was analyzed.Results 625 cases with MDR PTB received treatment before occupied 30.8% in patients of retreatment bacteriological positive PTB.Young and middle age females occupied majority.The results of susceptibility test wereas follows:7 cases with drug resistance results to H.R. (1.1%);125 cases with drug resistance results to 3 drugs (20.0%);493 cases with drug resistance results to H.R.S.E.( 78.9%); the initinl drug resistance rate was 19.4% and acquired resistance result was 80.6%.There were more patients in rural and town than ones in the city and the cure rate of patients come from rural area was lower than that of patients from urban area.Conclusion The treatment to post MDR PTB is more difficult than to general MDR PTB.Besides economic cultural and regional diffence,medical factor is one of mainly reasons of occurrence rate increasing.The rate of primary resistance in the cases is higher than the rate of national average resistance.The difference in effective rate of treatment in different area is because of there is short of regular treatment manage by specialist.The better effect can be got by the private treatment especially unite the operation treatment.
出处 《中国防痨杂志》 CAS 北大核心 2004年第5期277-279,共3页 Chinese Journal of Antituberculosis
关键词 复治 耐多药肺结核病 病人 MDR 临床特点 初始耐药 治疗 因素 结论 专业人员 Pulmonary tuberculosis MDR-TB Post-retreatment
  • 相关文献

参考文献4

二级参考文献20

  • 1何国钧.抗结核药物的研究进展[J].中国防痨杂志,1996,18(3):136-139. 被引量:47
  • 2Mukund Uplekar 肖和平等(译).结核病临床手册[M].上海:复旦大学出版社,1999.50-54.
  • 3John Crofton Norman Horne Fred Miller(王撷秀 屠德华 安燕生译).临床结核病:第2版[M].北京:科学出版社,2000.160~162.
  • 4肖和平 何国钧.结核分支杆菌感染[A].见:汪复主编.抗感染药物临床应用手册[C].北京:人民卫生出版社,2001.102~106.
  • 5John Crofton Pierre Chaulet Dermot Maker(肖和平 杨敏译).耐药结核病处理指南[M].上海:卫生部结核病控制分中心,1997.4~41.
  • 6陈新谦 金有豫 编.新编药物学:第12版[M].北京:人民卫生出版社,1988.130~136.
  • 7肖和平.肺结核诊治进展[A].见:黄绍光主编.肺内科新进展[C].北京:人民卫生出版社,2000.178~201.
  • 8中华人民共和国卫生部疾病控制司.中国结核病防治规划实施工作指南[M].北京:中华人民共和国卫生部,2002.6-34.
  • 9肖和平 何国钧.耐多药结核病诊断与处理的研讨[J].中国防痨杂志,1999,21:21-22.
  • 10中华人民共和国卫生部疾病控制司 卫生部医政司.全国结核病防治工作手册[M].北京,1999.52~61.

共引文献183

同被引文献133

引证文献10

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部